Tested Applications
| Positive WB detected in | COLO 320 cells, A549 cells, HEK-293 cells, L02 cells |
| Positive IP detected in | COLO 320 cells |
| Positive IHC detected in | human colon cancer Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells, L02 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11177-1-AP targets OGFR in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1671 Product name: Recombinant human OGFR protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 358-658 aa of BC014137 Sequence: LERSQGDEAGGHGEDRPEPLSPKESKKRKLELSRREQPPTEPGPQSASEVEKIALNLEGCALSQGSLRTGTQEVGGQDPGEAVQPCRQPLGARVADKVRKRRKVDEGAGDSAAVASGGAQTLALAGSPAPSGHPKAGHSENGVEEDTEGRTGPKEGTPGSPSETPGPSPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAESPSETPGPRPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAKAGEAAELQDAEVESSAKSGKP Predict reactive species |
| Full Name | opioid growth factor receptor |
| Calculated Molecular Weight | 73 kDa |
| Observed Molecular Weight | 90-110 kDa |
| GenBank Accession Number | BC014137 |
| Gene Symbol | OGFR |
| Gene ID (NCBI) | 11054 |
| RRID | AB_2156772 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NZT2 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for OGFR antibody 11177-1-AP | Download protocol |
| IHC protocol for OGFR antibody 11177-1-AP | Download protocol |
| IP protocol for OGFR antibody 11177-1-AP | Download protocol |
| WB protocol for OGFR antibody 11177-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The OGFR Polyclonal antibody (Cat# 11177-1-AP) has 16 citations published in journals including International Immunopharmacology, International Journal of Biological Sciences, International Journal of Molecular Sciences, Nature Communications, Frontiers in Oncology, PLoS One, Cancer Management Research, American Journal of Clinical and Experimental Urology, and bioRxiv. Research fields span oncology (squamous cell, lung, gastric, colorectal, cervical, prostate, and osteosarcoma cancers), tumor microenvironment immunology, opioid signaling, cardiotoxicity, and autophagy.
| Species | Application | Title |
|---|---|---|
Int J Biol Sci CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy.
| ||
Int Immunopharmacol Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment | ||
Int Immunopharmacol In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma
| ||
Int J Mol Sci Naltrexone Has Variable and Schedule-Dependent Effects on Oral Squamous Cell Carcinoma Cells. | ||
Int Immunopharmacol A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
| ||
Int Immunopharmacol Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition |















